ID: ALA6528

Max Phase: Preclinical

Molecular Formula: C19H24N2

Molecular Weight: 280.42

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(C)CC1c2ccccc2C(c2ccccc2)CN1C

Standard InChI:  InChI=1S/C19H24N2/c1-20(2)14-19-17-12-8-7-11-16(17)18(13-21(19)3)15-9-5-4-6-10-15/h4-12,18-19H,13-14H2,1-3H3

Standard InChI Key:  RJXXPJSDBLRNBL-UHFFFAOYSA-N

Associated Targets(non-human)

Muscarinic acetylcholine receptor M5 132 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 280.42Molecular Weight (Monoisotopic): 280.1939AlogP: 3.37#Rotatable Bonds: 3
Polar Surface Area: 6.48Molecular Species: BASEHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.98CX LogP: 3.53CX LogD: 1.94
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.85Np Likeness Score: -0.02

References

1. Griffith RC, Gentile RJ, Robichaud RC, Frankenheim J..  (1984)  cis-1,3,4,6,7,11b-Hexahydro-2-methyl-7-phenyl-2H-pyrazino[2,1-a] isoquinoline: a new atypical antidepressant.,  27  (8): [PMID:6747997] [10.1021/jm00374a011]

Source